Jiangsu Recbio Technology Co., Ltd.

HKEX:2179.HK

8.4 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019
Operating Activities:
Net Income -572.443-735.996-657.566-179.4-138.27
Depreciation & Amortization 63.89840.93522.45812.7634.326
Deferred Income Tax -16.5210-2.70700
Stock Based Compensation 41.89347.816137.68900
Change In Working Capital -125.365203.272-18.74864.315-68.21
Accounts Receivables 00000
Inventory -45.628-32.611-15.787-0.399-7.018
Accounts Payables 00000
Other Working Capital -79.737235.883-2.96164.714-61.192
Other Non Cash Items -29.534-135.56845.95331.98663.515
Operating Cash Flow -638.072-579.541-472.921-70.336-138.639
Investing Activities:
Investments In Property Plant And Equipment -224.11-308.498-237.867-170.733-78.966
Acquisitions Net 00002.37
Purchases Of Investments 0-107.462-40-145-280
Sales Maturities Of Investments 187.95413.558336.21654.5158.762
Other Investing Activites 45.5823.97510.3552.6312.195
Investing Cash Flow 9.424-378.42768.704-258.587-345.639
Financing Activities:
Debt Repayment -12.021-0.5-6.42-5.871-5.976
Common Stock Issued -100669.714000
Common Stock Repurchased -1000000
Dividends Paid 00000
Other Financing Activities 45.6170.2231,235.868686.256496.147
Financing Cash Flow 275.275839.4371,229.448680.385490.171
Other Information:
Effect Of Forex Changes On Cash 19.264115.061-8.49-2.880
Net Change In Cash -334.109-3.47816.741348.5825.893
Cash At End Of Period 834.9831,169.0921,172.562355.8217.239